DJ AbbVie Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. $(ABBV)$ slid 1.13% to $202.71 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.38% to 7,337.11 and Dow Jones Industrial Average falling 0.63% to 49,596.97.
This was the stock's third consecutive day of losses.
AbbVie Inc. closed 17.20% below its 52-week high of $244.81, which the company reached on October 1st.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 0.94% to $222.51, Pfizer Inc. $(PFE)$ fell 0.19% to $26.48, and Amgen Inc. $(AMGN)$ fell 0.61% to $329.09.
Trading volume (6.3 M) remained 689,071 below its 50-day average volume of 7.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 7, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 07, 2026 16:32 ET (20:32 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments